Lord J, McMullan DJ, Eberhardt RY, Rinck G, Hamilton SJ, Quinlan-Jones E, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet. 2019;393:747–57.
Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393:758–67.
Diderich KEM, Bruggenwirth HT, Joosten M, Thurik F, Mijalkovic J, Polak M, et al. The high diagnostic yield of prenatal exome sequencing followed by 3400 gene panel analysis in 629 ongoing pregnancies with ultrasound anomalies. Prenat Diagn. 2024;44:1444–50.
de Koning MA, Haak MC, Adama van Scheltema PN, Peeters-Scholte C, Koopmann TT, Nibbeling EAR, et al. From diagnostic yield to clinical impact: a pilot study on the implementation of prenatal exome sequencing in routine care. Genet Med. 2019;21:2303–10.
Mastromoro G, Guadagnolo D, Khaleghi Hashemian N, Marchionni E, Traversa A, Pizzuti A. Molecular approaches in fetal malformations, dynamic anomalies and soft markers: diagnostic rates and challenges-systematic review of the literature and meta-analysis. Diagnostics. 2022;23;12:575.
Van den Veyver IB, Chandler N, Wilkins-Haug LE, Wapner RJ, Chitty LS. International Society for Prenatal Diagnosis Updated Position Statement on the use of genome-wide sequencing for prenatal diagnosis. Prenat Diagn. 2022;42:796–803.
Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results. Obstet Gynecol. 2017;129:e96-e101.
Committee Opinion No.682: Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol. 2016;128:e262-e268.
Klapwijk JE, Srebniak MI, Go A, Govaerts LCP, Lewis C, Hammond J, et al. How to deal with uncertainty in prenatal genomics: A systematic review of guidelines and policies. Clin Genet. 2021;100:647–58.
Harding E, Hammond J, Chitty LS, Hill M, Lewis C. Couples experiences of receiving uncertain results following prenatal microarray or exome sequencing: a mixed-methods systematic review. Prenat Diagn. 2020;40:1028–39.
Lewis C, Hammond J, Klapwijk JE, Harding E, Lou S, Vogel I, et al. Dealing with uncertain results from chromosomal microarray and exome sequencing in the prenatal setting: An international cross-sectional study with healthcare professionals. Prenat Diagn. 2021;41:720–32.
Diderich KEM, Klapwijk JE, van der Schoot V, van den Born M, Wilke M, Joosten M, et al. The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis. Eur J Med Genet. 2023;66:104844.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Shi P, Liang H, Hou Y, Chen D, Ren H, Wang C, et al. The uncertainty of copy number variants: pregnancy decisions and clinical follow-up. Am J Obstet Gynecol. 2023;229:170.e1–e8.
Zhou Q, Chu PH, Huang C, Cheng CF, Martone ME, Knoll G, et al. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol. 2001;155:605–12.
Koopmann TT, Jamshidi Y, Naghibi-Sistani M, van der Klift HM, Birjandi H, Al-Hassnan Z, et al. Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy. Eur J Hum Genet. 2023;31:97–104.
Urquhart JE, Beaman G, Byers H, Roberts NA, Chervinsky E, O’Sullivan J, et al. DMRTA2 (DMRT5) is mutated in a novel cortical brain malformation. Clin Genet. 2016;89:724–7.
Wei W, Li B, Li F, Sun K, Jiang X, Xu R. Identification of FOXH1 mutations in patients with sporadic conotruncal heart defect. Clin Genet. 2020;97:576–85.
Tuzovic L, Yu L, Zeng W, Li X, Lu H, Lu HM, et al. A human de novo mutation in MYH10 phenocopies the loss of function mutation in mice. Rare Dis. 2013;1:e26144.
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–30.
Durkie M, Cassidy E, Berry I, Owens M, Turnbull C, Scott RH, et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease: Association for Clinical Genomic Science; 2024 [updated 20 February 2024. Available from: https://www.acgs.uk.com/media/11631/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf.
Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110:1046–67.
Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat. 2018;39:1517–24.
Landrum MJ, Chitipiralla S, Kaur K, Brown G, Chen C, Hart J, et al. ClinVar: updates to support classifications of both germline and somatic variants. Nucleic Acids Res. 2025;53:D1313–d21.
Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen-tHE CLINICAL GENOME REsource. N Engl J Med. 2015;372:2235–42.
Basel-Salmon L, Sukenik-Halevy R. Challenges in variant interpretation in prenatal exome sequencing. Eur J Med Genet. 2022;65:104410.
Group CSVIW. SVI Recommendation for De Novo Criteria (PS2 & PM6) – Version 1.1 2021 [Available from: https://clinicalgenome.org/site/assets/files/3461/svi_proposal_for_de_novo_criteria_v1_1.pdf.
Hammond J, Klapwijk JE, Riedijk S, Lou S, Ormond KE, Vogel I, et al. Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design. PLoS ONE. 2022;17:e0261898.
Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ. Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med. 2013;15:139–45.
Talati AN, Gilmore KL, Hardisty EE, Lyerly AD, Rini C, Vora NL. Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosis. Prenat Diagn. 2022;42:775–82.
Watts G, Newson AJ. To offer or request? Disclosing variants of uncertain significance in prenatal testing. Bioethics. 2021;35:900–9.
Hui L, Szepe E, Halliday J, Lewis C. Maternity health care professionals’ views and experiences of fetal genomic uncertainty: a review. Prenat Diagn. 2020;40:652–60.
Horn R, Parker M. Opening Pandora’s box?: ethical issues in prenatal whole genome and exome sequencing. Prenat Diagn. 2018;38:20–5.
Cohen JL, Duyzend M, Adelson SM, Yeo J, Fleming M, Ganetzky R, et al. Advancing precision care in pregnancy through an actionable fetal findings list. medRxiv. 2024:2024.09.26.24314442.